Evidence Library
Filter by drug, type, year, and open access.
Showing 1–50 of 89 results
- Autonomic dysfunctions in psychotic disorders, interaction with antipsychotic intervention and treatment resistance: a comprehensive systematic review and meta-analysis — Journal of Psychiatric Research (2026)• Drug: clozapinePMID
- Efficacy of combined nicotine replacement therapy (NRT) and bupropion compared to bupropion alone for smoking cessation: a systematic review and meta-analysis — Addictive Behaviors (2026)• Drug: bupropionPMID
- Prevalence of dermatologic side effects of mood stabilizers in bipolar disorder: A systematic review and meta-analysis — Journal of Psychiatric Research (2026)• Drug: carbamazepinePMID
- Prevalence of dermatologic side effects of mood stabilizers in bipolar disorder: A systematic review and meta-analysis — Journal of Psychiatric Research (2026)• Drug: lithiumPMID
- Transdiagnostic effectiveness and safety of clozapine in individuals with psychotic, affective, and personality disorders: nationwide and meta-analytic comparisons with other antipsychotics — The Lancet Psychiatry (2025)• Drug: clozapinePMID
- Antipsychotic-related prolactin changes: a systematic review and dose-response meta-analysis — CNS Drugs (2025)• Drug: brexpiprazolePMID
- Antipsychotic-related prolactin changes: a systematic review and dose-response meta-analysis — CNS Drugs (2025)• Drug: quetiapinePMID
- Comparative gastrointestinal effects of antidepressants for the acute treatment of adults with major depressive disorder: a network and dose-response meta-analysis — Translational Psychiatry (2025)• Drug: levomilnacipranPMID
- The effects of antidepressants on cardiometabolic and other physiological parameters: a systematic review and network meta-analysis — The Lancet (2025)• Drug: levomilnacipranPMID
- Effect of antidepressants on ejaculation dysfunction in patients with depression and anxiety: a systematic review and network meta-analysis — Andrology (2025)• Drug: levomilnacipranPMID
- Gene expression signatures of response to fluoxetine treatment: systematic review and meta-analyses — Molecular Psychiatry (2025)• Drug: fluoxetinePMID
- Selective serotonin reuptake inhibitors and quality of life: a meta-analysis of randomized placebo-controlled trials — International Clinical Psychopharmacology (2025)• Drug: paroxetinePMID
- Comparative efficacy and safety of daridorexant, lemborexant, and suvorexant for insomnia: a systematic review and network meta-analysis — Translational Psychiatry (2025)• Drug: suvorexantOpen accessDOIPMIDPMCID
- Comparative efficacy and safety of daridorexant, lemborexant, and suvorexant for insomnia: a systematic review and network meta-analysis — Translational Psychiatry (2025)• Drug: lemborexantOpen accessDOIPMIDPMCID
- Comparative efficacy and safety of daridorexant, lemborexant, and suvorexant for insomnia: a systematic review and network meta-analysis — Translational Psychiatry (2025)• Drug: daridorexantOpen accessDOIPMIDPMCID
- Beta-blockers for the treatment of anxiety disorders: A systematic review and meta-analysis — Journal of Affective Disorders (2025)• Drug: propranololDOI
- Sustained-release naltrexone for opioid dependence — Cochrane Database of Systematic Reviews (2025)• Drug: naltrexone-extended-releaseDOIPMID
- Comparative gastrointestinal effects of antidepressants for the acute treatment of adults with major depressive disorder: a network and dose-response meta-analysis — Translational Psychiatry (2025)• Drug: amitriptylinePMID
- Efficacy and tolerability of antidepressants in individuals suffering from physical conditions and depressive disorders: network meta-analysis — The British Journal of Psychiatry (2025)• Drug: amitriptylinePMID
- Efficacy and tolerability of antidepressants in individuals suffering from physical conditions and depressive disorders: network meta-analysis — The British Journal of Psychiatry (2025)• Drug: desipraminePMID
- Effect of antidepressants on ejaculation dysfunction in patients with depression and anxiety: a systematic review and network meta-analysis — Andrology (2025)• Drug: imipraminePMID
- Efficacy and tolerability of antidepressants in individuals suffering from physical conditions and depressive disorders: network meta-analysis — The British Journal of Psychiatry (2025)• Drug: imipraminePMID
- Effect of mood stabilizers on cognition in bipolar disorder: A systematic review and meta-analysis of randomized controlled trials — Journal of Affective Disorders (2025)• Drug: lithiumPMID
- Efficacy of Different Combination Therapies for Mania in Bipolar Disorder: A systematic review and meta-analysis — Brain and Behavior (2025)• Drug: lithiumPMID
- The efficacy and safety of trazodone for sleep problems in depressive patients — Psychopharmacology (2025)• Drug: trazodoneDOI
- The efficacy of lamotrigine in bipolar disorder: a systematic review and meta-analysis — Bipolar Disorders (2024)• Drug: lamotrigineDOIPMID
- Residual effects of medications for sleep disorders on driving performance — European Neuropsychopharmacology (2024)• Drug: estazolamDOI
- Residual effects of medications for sleep disorders on driving performance — European Neuropsychopharmacology (2024)• Drug: flurazepamDOI
- Residual effects of medications for sleep disorders on driving performance — European Neuropsychopharmacology (2024)• Drug: quazepamDOI
- Residual effects of medications for sleep disorders on driving performance — European Neuropsychopharmacology (2024)• Drug: temazepamDOI
- Residual effects of medications for sleep disorders on driving performance — European Neuropsychopharmacology (2024)• Drug: triazolamDOI
- Comparative efficacy and tolerability of pharmacological interventions for acute bipolar depression in adults: a network meta-analysis. — The Lancet Psychiatry (2023)• Drug: lurasidoneDOIPMID
- Pharmacological treatments in panic disorder in adults: a network meta-analysis — Cochrane Database of Systematic Reviews (2023)• Drug: alprazolamOpen accessDOIPMIDPMCID
- Pharmacotherapy for Alcohol Use Disorder: A Systematic Review and Meta-Analysis — JAMA (2023)• Drug: naltrexoneOpen accessDOIPMIDPMCID
- Pharmacotherapy for Alcohol Use Disorder: A Systematic Review and Meta-Analysis — JAMA (2023)• Drug: acamprosateOpen accessDOIPMIDPMCID
- Pharmacotherapy for Alcohol Use Disorder: A Systematic Review and Meta-Analysis — JAMA (2023)• Drug: disulfiramOpen accessDOIPMIDPMCID
- Nicotine receptor partial agonists for smoking cessation — Cochrane Database of Systematic Reviews (2023)• Drug: vareniclineOpen accessDOIPMIDPMCID
- Pharmacological treatment for bipolar mania: network meta-analysis of RCTs. — Molecular Psychiatry (2022)• Drug: quetiapineOpen accessDOIPMIDPMCID
- Pharmacological treatments for antipsychotic-induced hyperprolactinemia: network meta-analysis. — Translational Psychiatry (2022)• Drug: risperidoneOpen accessDOIPMIDPMCID
- Comparative effects of pharmacological interventions for the acute and long-term management of insomnia disorder in adults: systematic review and network meta-analysis — The Lancet (2022)• Drug: eszopicloneDOIPMID
- Comparative effects of pharmacological interventions for the acute and long-term management of insomnia disorder in adults: systematic review and network meta-analysis — The Lancet (2022)• Drug: zolpidemDOIPMID
- Comparative effects of pharmacological interventions for the acute and long-term management of insomnia disorder in adults: systematic review and network meta-analysis — The Lancet (2022)• Drug: ramelteonDOIPMID
- Comparative effects of pharmacological interventions for the acute and long-term management of insomnia disorder in adults: systematic review and network meta-analysis — The Lancet (2022)• Drug: zaleplonDOIPMID
- Treatment of central disorders of hypersomnolence: an American Academy of Sleep Medicine systematic review, meta-analysis, and GRADE assessment — Journal of Clinical Sleep Medicine (2021)• Drug: calcium-magnesium-potassium-and-sodium-oxybatesDOI
- Treatment of central disorders of hypersomnolence: an American Academy of Sleep Medicine systematic review, meta-analysis, and GRADE assessment — Journal of Clinical Sleep Medicine (2021)• Drug: sodium-oxybate-extended-releaseDOI
- Efficacy of Quetiapine in Bipolar Depression: Meta‑analysis — Meta‑analysis (2020)• Drug: quetiapine
- Comparative effects of 18 antipsychotics on metabolic function in schizophrenia: systematic review and network meta-analysis. — The Lancet Psychiatry (2020)• Drug: olanzapineOpen accessDOIPMIDPMCID
- Lurasidone in bipolar depression: meta‑analysis — Meta‑analysis (2020)• Drug: lurasidone
- The effects of prazosin on sleep disturbances in post-traumatic stress disorder: systematic review and meta-analysis — Sleep Medicine (2020)• Drug: prazosinOpen accessDOIPMIDPMCID
- Treatment interventions to maintain abstinence from alcohol in primary care: systematic review and network meta-analysis — BMJ (2020)• Drug: acamprosateOpen accessDOIPMIDPMCID